Does MOXONIDINE Cause Hepatic lesion? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatic lesion have been filed in association with MOXONIDINE. This represents 0.6% of all adverse event reports for MOXONIDINE.
5
Reports of Hepatic lesion with MOXONIDINE
0.6%
of all MOXONIDINE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hepatic lesion From MOXONIDINE?
Of the 5 reports, 5 (100.0%) required hospitalization, and 5 (100.0%) were considered life-threatening.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOXONIDINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does MOXONIDINE Cause?
Hypotension (97)
Renal impairment (86)
Dizziness (85)
Hyperkalaemia (76)
Abdominal pain (69)
Acute kidney injury (67)
Bradycardia (58)
Drug ineffective (55)
Hypertension (55)
Nausea (50)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
RIBOCICLIB (144)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
Which MOXONIDINE Alternatives Have Lower Hepatic lesion Risk?
MOXONIDINE vs MS CONTIN
MOXONIDINE vs MULTAQ
MOXONIDINE vs MULTIHANCE
MOXONIDINE vs MUPIROCIN
MOXONIDINE vs MUPIROCIN\MUPIROCIN